Latest Stock Split Details
Key information about NLS Pharmaceutics AG's most recent stock split
Split Date: 2025-10-31
Split Ratio: 1:10
Price Before Split: $0.76
Price After Split: $0.08
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 10.00 times fewer shares (a 1:10 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of NLS Pharmaceutics AG's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2025-10-31 | 1:10 | Yes | $0.76 | $0.08 |
| 2024-09-27 | 1:40 | Yes | $0.13 | $0.00 |
About NLS Pharmaceutics AG
Company overview and industry information
NLS Pharmaceutics AG (NLSP) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to NLS Pharmaceutics AG Summary